Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ALLO

Allogene Therapeutics Inc

May 05 • 04:00PM ET

2.17

-0.09 -3.98 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: NTLA CRSP EDIT BEAM FDMT IOBT SGMO CLLS DTIL CYTK

| Held by: XBI VTI IWM VXF IBB IWN SCHA DFAS VTWO FESM

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.87	Insider Own	37.48%	Shs Outstand	229.41M	Perf Week	-0.91%
Market Cap	718.87M	Forward P/E	-	EPS next Y	-0.74	Insider Trans	-0.23%	Shs Float	207.13M	Perf Month	-16.54%
Enterprise Value	551.91M	PEG	-	EPS next Q	-0.19	Inst Own	34.63%	Short Float	17.56%	Perf Quarter	24.71%
Income	-190.89M	P/S	-	EPS this Y	14.26%	Inst Trans	0.51%	Short Ratio	3.91	Perf Half Y	75.00%
Sales	0.00M	P/B	1.70	EPS next Y	0.93%	ROA	-39.58%	Short Interest	36.38M	Perf YTD	58.39%
Book/sh	1.28	P/C	2.87	EPS next 5Y	8.62%	ROE	-53.42%	52W High	4.46 -51.35%	Perf Year	33.95%
Cash/sh	0.76	P/FCF	-	EPS past 3/5Y	28.61% 16.08%	ROIC	-51.93%	52W Low	0.86 151.71%	Perf 3Y	-67.12%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	5.87% 11.46%	Perf 5Y	-92.44%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	34.97%	Oper. Margin	-	ATR (14)	0.23	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	7.93	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	44.71	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	7.93	EPS Q/Q	39.67%	SMA20	-8.92%	Beta	0.45	Target Price	8.65
Payout	-	Debt/Eq	0.28	Sales Q/Q	-	SMA50	-10.13%	Rel Volume	0.63	Prev Close	2.26
Employees	152	LT Debt/Eq	0.26	Earnings	Mar 12 AMC	SMA200	33.55%	Avg Volume	9.31M	Price	2.17
IPO	Oct 11, 2018	Option/Short	Yes / Yes	EPS/Sales Surpr.	24.61% -100.00%	Trades		Volume	5,818,501	Change	-3.98%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)